Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Withdrawal because of adverse effects
RCT	30 people with CFS (CDC 1988 criteria) In review	Withdrawal because of adverse effects 6 weeks 3/15 (20%) with phenelzine 0/15 (0%) with placebo	Significance not assessed